Helping the injured since 1983

Contact us at (866) 303-2514 to schedule a FREE consultation today.

Get Help NOW!



Posted on Tuesday, September 18th, 2018 at 4:28 am by Williams Hart   

DEXILANT (Dexlansoprazole) Lawsuit

If you or your loved one is suffering from chronic kidney disease (CKD), renal failure, or an acute kidney injury caused by DEXILANT, it is in your best interest to obtain legal representation. Williams Hart helps people with proton pump inhibitor (PPI) claims.

Our firm has been fighting for injury victims for more than 35 years. We understand the complexity of DEXILANT claims and work to make sure that drug manufacturers are held accountable for their negligence.

At Williams Hart, our record of success includes numerous verdicts and settlements totaling billions of dollars. Many DEXILANT actions have already been filed in courts all over the nation, and some of the recent decisions include:

$7.9 Million – AstraZeneca – 2015 – Kickbacks to Pharmacy Benefit Managers

  • AstraZeneca settled a lawsuit brought by the United States Government for $7.9 million, alleging that it had paid kickbacks to Medco Health Solutions to ensure that its PPI was the only one covered by the pharmacy benefits management company.

$20 Million – AstraZeneca – 2015 – Deceptive Advertising

  • AstraZeneca also had to pay $20 million to settle a lawsuit stemming from an advertising campaign it ran that exaggerated the differences between two of its largely identical PPIs, Nexium and Prilosec.

$24 Million – Teva Pharmaceuticals – 2015 – Paying Off Competition

  • Generic pharmaceutical manufacturer Teva Pharmaceuticals had to pay $24 million to settle a class-action lawsuit stemming from an allegation that it accepted money from AstraZeneca to delay the production of generic forms of a PPI.

$55 Million – Pfizer Inc. – 2012 – Off-Label Advertising

  • After promoting a PPI for off-label use as a treatment for other types of gastroesophageal reflux disease (GERD or “acid reflux”), Pfizer was sued and had to pay $55 million to settle the case. Physicians can legally prescribe medications for off-label uses, but pharmaceutical companies cannot advertise drugs for purposes they have not been approved for.

While these settlements provide an idea of the large sums of money that can be involved in legal decisions, it is important to remember that the monetary amount of a settlement depends on the unique aspects of an individual’s case.


Dexlansoprazole is better known by its trade name DEXILANT, which is manufactured by Takeda Pharmaceuticals. DEXILANT is generally used for the treatment of GERD and erosive esophagitis, or inflammation of the esophagus.

Dexlansoprazole was approved by the United States Food and Drug Administration (FDA) in 2009 and was originally marketed under the name Kapidex. That name, however, led to dispensing errors because of confusion with two other similarly named drugs with very different uses, leading to Takeda changing the name to DEXILANT.

According to Takeda, DEXILANT generated $457 million in sales in the fiscal year 2016. Sales totaled $530 million in 2015 and $488 million in 2014.

Some studies have linked PPIs such as DEXILANT to serious side effects like kidney disease and kidney failure. These debilitating injuries have led victims to file lawsuits against Takeda over DEXILANT.

Have you or your loved one suffered kidney damage or another ailment after using DEXILANT? Call (866) 303-2514 to have the lawyers of Williams Hart provide an honest and complete evaluation of your case during a free consultation.

You Could Be Owed Compensation

Drug manufacturers have an obligation to conduct the necessary tests before submitting medications for approval by the FDA. Additionally, the manufacturer is expected to inform consumers of all the potential side effects of using their drugs.

When a drug manufacturer fails to fulfill these obligations, a person may file a product liability claim against the manufacturer, when the use of the drug has resulted in severe injuries. It is ultimately the drug manufacturer, not the FDA, that is responsible for ensuring the warning labels on medicines are accurate, and a manufacturer can be held liable for putting a dangerous drug on the market.

Chronic Kidney Disease and DEXILANT

In recent years, a growing body of research has shown that many PPIs can have very damaging effects on a person’s kidneys. Because kidneys help keep bones healthy, remove wastes and extra fluid, and make red blood cells, in addition to other functions, the health of these organs is vitally important.

PPIs can result in possible chronic kidney disease (CKD), which can lead to such symptoms as:

  • Vomiting
  • Sleep problems
  • Shortness of breath
  • Nausea
  • Muscle twitches
  • Itching
  • High blood pressure
  • Fatigue
  • Decreased mental sharpness
  • Cramps
  • Chest pain

Certain individuals may be predisposed to CDK risks, such as those with abnormal kidney structure or with a family history of kidney disease. Other factors may also increase a person’s risk of CKD, such as smoking, old age, diabetes, and obesity.

Another group at heightened risk are pregnant women because CDK affects the health of the mother as well as that of the unborn child. CDK can involve numerous complications, including possible cardiovascular disease or anemia.

Additional complications may include:

  • Hyperkalemia (increased potassium levels in the blood that could affect heart function)
  • Fluid-retention issues leading to pulmonary edema (fluid in the lungs), swelling in the arms and legs, or high blood pressure
  • Pericarditis, swelling, and irritation of the pericardium, the thin sac-like membrane surrounding the heart
  • Damage to the central nervous system
  • Decreased immune response, increasing vulnerability to infection
  • Weakened bones and increased risk of fractures

CKD can cause irreversible damage such as kidney failure or end-stage renal disease (ESRD). In such cases, victims may require dialysis or a kidney transplant.

Anybody who suffers kidney problems after using DEXILANT should discuss these issues with their doctor. The next step should be to contact a lawyer for help filing a legal claim.

Why Choose Williams Hart?

When you work with Williams Hart, you will be represented by attorneys who have been fighting on behalf of injury victims for more than three decades. Our firm is committed to the protection and defense of our clients’ rights.

We have experience handling many types of personal injury cases, including the product liability claims that are at the heart of many PPI cases. Williams Hart not only has the support staff and resources necessary to handle such cases, but we also maintain relationships with some of the most reputable experts for investigatory and testimonial purposes.

As soon as you hire our firm, we will handle all communications on your behalf. We can negotiate a full and fair settlement, or we can file a lawsuit if necessary.

Williams Hart understands the dramatic effects that DEXILANT complications can have, and we are ready to do whatever we can to help restore normalcy to your life. Contact our firm to tell us your story during a free consultation.

Frequently Asked Questions

Certain questions are commonly asked in DEXILANT injury cases. Below, you can find answers to a few of the most common.

If you have other questions about a unique aspect to your case, do not hesitate to contact Williams Hart at (866) 303-2514.

If DEXILANT caused my CKD, who is at fault?

In a product liability action, the drug manufacturer is often the primary defendant. Legal claims may be based on Takeda’s marketing for DEXILANT, failure to warn of the drug’s risks, or knowingly hiding dangers of the drug from the public. Some claims may simply argue DEXILANT is a dangerous or defective medication. Doctors could also be liable when a patient was prescribed DEXILANT without displaying the symptoms specified by the FDA.

What has the FDA said about DEXILANT?

DEXILANT was among the PPIs listed by the FDA in a May 2010 in which the agency revised prescription and OTC labels to include new information regarding the increased risk of fractures of the wrist, hip, and spine caused by the use of these medications.

If my doctor had recommended DEXILANT for my health, should I continue to use it despite my CKD concerns?

Yes. Always consult your doctor before you switch medications or stop taking DEXILANT. The FDA has stated that PPIs remain “effective in treating a variety of gastrointestinal disorders.”

How much will it cost to hire a lawyer?

You may be facing a growing number of financial concerns stemming from your injury, but Williams Hart does not believe legal representation should be one of them. In addition to a free consultation, we also handle DEXILANT cases on a contingency fee basis, which means that you pay us nothing unless you receive a monetary award.

What types of compensation might I be entitled to?

Any damages you receive are usually based on the specific aspects of your case. Medical expenses are a frequent inclusion in most cases, but pain and suffering, treatment costs, lost wages, and emotional distress may also be factored into an award.

Contact a DEXILANT Lawsuit Attorney Today

Are you or your loved one currently suffering any kidney injury related to DEXILANT? If so, please contact Williams Hart as soon as possible.

Our firm can fight to help you receive due compensation that covers all of your past, present, and future needs. We are passionate about holding drugmakers accountable for the people they’ve harmed with their dangerous medications.

Williams Hart has been helping injury victims since 1983. You can have our lawyers review your case and discuss all of your legal options when you call (866) 303-2514 for a free consultation.

Why the U.S. Pays More Than Other Countries for Drugs

Posted on Tuesday, December 1st, 2015 at 11:42 am by Williams Hart   

Prescription drugs cost Norwegians substantially less than their American counterparts. This article in The Wall Street Journal looks at how the state-run healthcare systems of Norway and other countries use their bargaining power to drive down drug costs for citizens, and what prevents the U.S. Medicare system from doing the same for Americans.

The Side Effects of Risperdal

Posted on Friday, October 16th, 2015 at 10:41 am by Williams Hart   

Risperdal (risperidone) is the antipsychotic medicine which functions include changes in the chemical effects in the brain. It is normally a treatment for manic depression symptoms and schizophrenia.

The common side effects of Risperdal include headache, depressed mood, weight gain, tremors, agitation, constipation, and many others. According to, you should be alert after taking this medicine and must immediately seek medical help once the following occurs:

  • Tenderness/swelling of breasts, both in men and women; nipple discharge; missed menstruations
  • Indications of high blood sugar: dry mouth, increased thirst, drowsiness, increased urination
  • Painful penis erection
  • Harsh nervous system reaction such as high fever, fast or uneven heartbeats and rigid muscles
  • Indication of low platelet level: easy bruising, unusual bleeding of the mouth, nose, vagina, or rectum, purple or red spots under the skin listed further important information about Risperdal on their website.

If you have been affected by the negligence of Risperdal manufacturers, consult with our legal team at Williams Hart. Call us today at (713) 352-7071.

How Risperdal can cause vision loss

Posted on Wednesday, September 9th, 2015 at 11:20 am by Williams Hart   

Risperdal is an atypical antipsychotic drug widely used to treat symptoms of schizophrenia, irritability in people living with autism, and manic states of bipolar disorder. However, some studies have associated this drug with different adverse effects, including loss of vision.

Atypical antipsychotic drugs are known to block a neurotransmitter called dopamine, which results in overproduction of prolactin (a type of hormone released by the pituitary gland). This overproduction may cause the gland to increase in size, making it more prone to develop benign tumors (pituitary adenomas). As these tumors grow, they may push the optic nerves and cause vision loss.

There are instances when only one of the eyes is affected. But in cases where a tumor pushes the area of the optic bundle where optic nerves from each eye meet, total loss of vision may occur.

If you think Risperdal has caused you or your loved one to suffer from vision loss or any other side effects, our legal team at Williams Hart might be able to help you file a claim against the drug manufacturer involved. Call us at (713) 352-7071 today.

Pradaxa Manufacturers Worried by Internal Study

Posted on Thursday, February 6th, 2014 at 2:53 pm by Williams Hart   

Atrial fibrillation is a common disorder among people with irregular heartbeats. Patients who suffer from atrial fibrillation run a high risk of experiencing stroke, heart attack, and pulmonary embolism. In order to prevent the occurrence of these medical emergencies, physicians often prescribe an anticoagulant, like Pradaxa, to prevent dangerous blood clotting.

However, since its market release in 2010, Pradaxa has been linked to nearly 1,000 deaths related to excessive bleeding. Physicians are especially concerned about Pradaxa’s bleeding risks because, unlike older anticoagulants like warfarin, Pradaxa doesn’t have an antidote to counteract its blood thinning properties in emergency situations.

Though Pradaxa has caused excessive bleeding in some people, it has proved ineffective as an anticoagulant in other patients. Researchers cite individual patients’ metabolisms to explain the disparity in the drug’s efficacy.  In fact, a recent article in the New York Times revealed that the manufacturers of Pradaxa, Boehringer Ingelheim, were worried about an internal research study’s results that indicated that Pradaxa users could benefit from regular blood testing to see whether or not the drug was working. One of the drug’s more marketable qualities was that it didn’t require regular blood testing, which older anticoagulants required, to prove efficacy. Recently unsealed legal documents have indicated that not only did some people within Boehringer Ingelheim pressure the researcher who published this study to revise some of its findings, but others suggested the study be “quashed altogether.”

In the few years that Pradaxa has been available to patients, it has sold more that $2 billion worth of the anticoagulant.

The attorneys of Williams Hart are investigating the claims of individuals who have been affected negatively by Pradaxa. If you or someone you know has been injured by this drug, call our offices at (713) 352-7071 to speak with a member of our legal team.

Have you or a loved one been injured in an accident?

Contact us today at (713) 352-7071 to get a free, confidential case evaluation.